Pomegranate Juice for Prostate Health

Research suggests that pomegranate juice and its derived compounds — particularly polyphenols such as ellagitannins, anthocyanidins, and punicalagins — may have meaningful biological activity relevant to prostate health, with laboratory and animal studies consistently showing effects such as slowed cancer cell growth, triggered programmed cell death, reduced cellular migration, and suppression of inflammatory and tumor-promoting signaling pathways including NF-κB and mTOR. Studies indicate that these effects extend to both prostate cancer cell lines and benign prostatic hyperplasia models, and one line of research proposes that pomegranate polyphenols may selectively target cancer cells by interacting with the elevated copper concentrations found in malignant tissue. The available evidence base consists primarily of in vitro cell culture studies, animal models, and narrative or systematic reviews of preclinical findings, with two 2011 reviews and a 2021 systematic review characterizing the prostate cancer evidence as among the more compelling within pomegranate research broadly — though all sources acknowledge that rigorous human clinical trial data remain limited. Readers should also be aware that pomegranate compounds, particularly those from the peel, may inhibit liver enzymes responsible for metabolizing certain medications, which is a practical consideration raised by multiple studies in this body of research.